<bill session="117" type="s" number="3778" updated="2022-12-29T22:33:32Z">
  <state datetime="2022-03-08">REFERRED</state>
  <status>
    <introduced datetime="2022-03-08"/>
  </status>
  <introduced datetime="2022-03-08"/>
  <titles>
    <title type="display">Territories Medicare Prescription Drug Assistance Equity Act of 2022</title>
    <title type="short" as="introduced">Territories Medicare Prescription Drug Assistance Equity Act of 2022</title>
    <title type="official" as="introduced">A bill to amend titles XVIII and XIX of the Social Security Act to make premium and cost-sharing subsidies available to low-income Medicare part D beneficiaries who reside in Puerto Rico or another territory of the United States.</title>
  </titles>
  <sponsor bioguide_id="M000639"/>
  <cosponsors>
    <cosponsor bioguide_id="B001277" joined="2022-03-08"/>
    <cosponsor bioguide_id="B001288" joined="2022-03-08"/>
    <cosponsor bioguide_id="G000555" joined="2022-03-08"/>
    <cosponsor bioguide_id="L000570" joined="2022-03-16"/>
  </cosponsors>
  <actions>
    <action datetime="2022-03-08">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2022-03-08" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2022-04-01T21:00:45Z" status="Introduced in Senate">Territories Medicare Prescription Drug Assistance Equity Act of 2022

This bill makes certain subsidies under the Medicare prescription drug benefit available to beneficiaries who reside in Puerto Rico or&#160;another U.S. territory. Current law makes&#160;such beneficiaries ineligible for premium and cost-sharing subsidies, but&#160;establishes a process for&#160;U.S. territories&#160;to apply&#160;for financial assistance with respect to the provision of Medicare prescription drugs. The bill eliminates&#160;this process and makes the subsidies available to beneficiaries who reside in a&#160;U.S. territory&#160;and are otherwise eligible.</summary>
</bill>
